These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 24058301
21. Knowledge, Attitudes, and Practices regarding Diarrhea and Cholera following an Oral Cholera Vaccination Campaign in the Solomon Islands. Burnett E, Dalipanda T, Ogaoga D, Gaiofa J, Jilini G, Halpin A, Dietz V, Date K, Mintz E, Hyde T, Wannemuehler K, Yen C. PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004937. PubMed ID: 27548678 [Abstract] [Full Text] [Related]
22. Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia. Teshome S, Desai S, Kim JH, Belay D, Mogasale V. Hum Vaccin Immunother; 2018 Aug; 14(10):2427-2433. PubMed ID: 29648523 [Abstract] [Full Text] [Related]
23. The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study. Azman AS, Luquero FJ, Ciglenecki I, Grais RF, Sack DA, Lessler J. PLoS Med; 2015 Aug; 12(8):e1001867. PubMed ID: 26305226 [Abstract] [Full Text] [Related]
24. A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population. Cookson ST, Stamboulian D, Demonte J, Quero L, Martinez de Arquiza C, Aleman A, Lepetic A, Levine MM. Int J Epidemiol; 1997 Feb; 26(1):212-9. PubMed ID: 9126522 [Abstract] [Full Text] [Related]
25. Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh. Khan AI, Khan IA, Siddique SA, Rahman A, Islam MT, Bhuiya MAI, Saha NC, Biswas PK, Saha A, Chowdhury F, Qadri F. Hum Vaccin Immunother; 2019 Feb; 15(6):1302-1309. PubMed ID: 30261152 [Abstract] [Full Text] [Related]
26. Pregnancy Outcomes after a Mass Vaccination Campaign with an Oral Cholera Vaccine in Guinea: A Retrospective Cohort Study. Grout L, Martinez-Pino I, Ciglenecki I, Keita S, Diallo AA, Traore B, Delamou D, Toure O, Nicholas S, Rusch B, Staderini N, Serafini M, Grais RF, Luquero FJ. PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004274. PubMed ID: 26713614 [Abstract] [Full Text] [Related]
27. [Mass vaccination against cholera]. Rokstad IS. Tidsskr Nor Laegeforen; 2013 Jan 08; 133(1):24. PubMed ID: 23447822 [No Abstract] [Full Text] [Related]
28. Adapting to the global shortage of cholera vaccines: targeted single dose cholera vaccine in response to an outbreak in South Sudan. Parker LA, Rumunu J, Jamet C, Kenyi Y, Lino RL, Wamala JF, Mpairwe AM, Ciglenecki I, Luquero FJ, Azman AS, Cabrol JC. Lancet Infect Dis; 2017 Apr 08; 17(4):e123-e127. PubMed ID: 28109819 [Abstract] [Full Text] [Related]
29. The case for reactive mass oral cholera vaccinations. Reyburn R, Deen JL, Grais RF, Bhattacharya SK, Sur D, Lopez AL, Jiddawi MS, Clemens JD, von Seidlein L. PLoS Negl Trop Dis; 2011 Jan 25; 5(1):e952. PubMed ID: 21283614 [Abstract] [Full Text] [Related]
30. Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis. Naficy A, Rao MR, Paquet C, Antona D, Sorkin A, Clemens JD. JAMA; 1998 Feb 18; 279(7):521-5. PubMed ID: 9480362 [Abstract] [Full Text] [Related]
31. A case for control of cholera in Africa by vaccination. Holmgren J. Lancet Infect Dis; 2012 Nov 18; 12(11):818-9. PubMed ID: 22954656 [No Abstract] [Full Text] [Related]
32. Innovative vaccine delivery strategies in response to a cholera outbreak in the challenging context of Lake Chilwa. A rapid qualitative assessment. Heyerdahl LW, Ngwira B, Demolis R, Nyirenda G, Mwesawina M, Rafael F, Cavailler P, Bernard Le Gargasson J, Mengel MA, Gessner BD, Guillermet E. Vaccine; 2018 Oct 22; 36(44):6491-6496. PubMed ID: 29126808 [Abstract] [Full Text] [Related]
33. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam. Vu DT, Hossain MM, Nguyen DS, Nguyen TH, Rao MR, Do GC, Naficy A, Nguyen TK, Acosta CJ, Deen JL, Clemens JD, Dang DT. J Health Popul Nutr; 2003 Dec 22; 21(4):304-8. PubMed ID: 15043004 [Abstract] [Full Text] [Related]
34. A simplified vaccine for cholera outbreak control. The Lancet Infectious Diseases. Lancet Infect Dis; 2024 Jun 22; 24(6):557. PubMed ID: 38789155 [No Abstract] [Full Text] [Related]
35. Potential impact of reactive vaccination in controlling cholera outbreaks: an exploratory analysis using a Zimbabwean experience. Kim SY, Choi Y, Mason PR, Rusakaniko S, Goldie SJ. S Afr Med J; 2011 Sep 05; 101(9):659-64. PubMed ID: 21920160 [Abstract] [Full Text] [Related]
36. Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. Thiem VD, Deen JL, von Seidlein L, Canh DG, Anh DD, Park JK, Ali M, Danovaro-Holliday MC, Son ND, Hoa NT, Holmgren J, Clemens JD. Vaccine; 2006 May 15; 24(20):4297-303. PubMed ID: 16580760 [Abstract] [Full Text] [Related]
37. Stockpiling oral cholera vaccine. Martin S, Costa A, Perea W. Bull World Health Organ; 2012 Oct 01; 90(10):714. PubMed ID: 23109735 [No Abstract] [Full Text] [Related]
39. Haiti prepares for cholera vaccination but concerns remain. Adams P. Lancet; 2012 Jan 07; 379(9810):16. PubMed ID: 22232798 [No Abstract] [Full Text] [Related]
40. Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh. Sarker AR, Islam Z, Khan IA, Saha A, Chowdhury F, Khan AI, Cravioto A, Clemens JD, Qadri F, Khan JA. Vaccine; 2015 Sep 11; 33(38):4916-21. PubMed ID: 26232545 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]